Concert Pharmaceuticals Inc banner
C

Concert Pharmaceuticals Inc
F:73C

Watchlist Manager
Concert Pharmaceuticals Inc
F:73C
Watchlist
Price: 7.818 EUR
Market Cap: €374.8m

Wall Street
Price Targets

73C Price Targets Summary
Concert Pharmaceuticals Inc

There are no price targets for 73C.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Concert Pharmaceuticals Inc Competitors:
Price Targets
LVS
Las Vegas Sands Corp
24% Upside
NN
NextNav Inc
50% Upside
LAND
Gladstone Land Corp
1% Upside

Revenue
Forecast

3% / Year
Past Growth
-89% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
3% / Year
Past Growth
-89% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 8 years the compound annual growth rate for Concert Pharmaceuticals Inc's revenue is 3%. The projected CAGR for the next 1 year is -89%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Concert Pharmaceuticals Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 73C's stock price target?
Not Available

73C doesn't have any price targets made by Wall Street professionals.

What is Concert Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-89%

For the last 8 years the compound annual growth rate for Concert Pharmaceuticals Inc's revenue is 3%. The projected CAGR for the next 1 year is -89%.

Back to Top